Description: Cybin is a leading ethical biopharmaceutical company, working with a network of world-class partners and internationally-recognized scientists, on a mission to create safe and effective therapeutics for patients to address a multitude of mental health issues.
We are working with a network of world-renowned partners and pioneers in the field to create safe and effective psychedelic-based therapies. Together, we believe we can discover, develop and commercialize novel therapies that will transform the mental health treatment landscape.
Watch Video Sign up to receive news and updates. Email Address Submit What We do We’re on a mission to revolutionize mental healthcare. At Cybin, we’re on a mission to revolutionize mental healthcare by engineering proprietary drug discovery platforms, innovative drug delivery systems, novel formulation approaches and treatment regimens to address the unmet needs of patients across a multitude of mental health issues.
Watch Video Sign up to receive news and updates. Email Address Submit Led by Science Our strategy is to combine novel psychedelic molecules with controllable drug delivery systems through our proprietary deuterated process. With our approach, we are engineering next-generation psychedelic, patent-protected, commercially scalable drug candidates to further evolve mental health treatments.
ICPR 2024 - Europe's Conference on Psychedelic Research & Therapy
PAREA - Towards safe, effective and accessible psychedelic therapies in Europe
PsyCan - Home
Noetic Fund
Cybin - Changing Minds
Mushroomstocks | Mushroom Stocks
PSYCH Symposium: London
SonderCo